Search for other papers by Lasse Oinonen in
Google Scholar
PubMed
Department of Clinical Physiology, Tampere University Hospital, Tampere, Finland
Search for other papers by Antti Tikkakoski in
Google Scholar
PubMed
Department of Internal Medicine, Tampere University Hospital, Tampere, Finland
Search for other papers by Jenni Koskela in
Google Scholar
PubMed
Search for other papers by Arttu Eräranta in
Google Scholar
PubMed
Department of Clinical Physiology, Tampere University Hospital, Tampere, Finland
Search for other papers by Mika Kähönen in
Google Scholar
PubMed
Search for other papers by Onni Niemelä in
Google Scholar
PubMed
Department of Internal Medicine, Tampere University Hospital, Tampere, Finland
Search for other papers by Jukka Mustonen in
Google Scholar
PubMed
Department of Internal Medicine, Tampere University Hospital, Tampere, Finland
Search for other papers by Ilkka Pörsti in
Google Scholar
PubMed
regulator of calcium levels ( 23 ), is associated with central BP and its haemodynamic determinants in 622 normotensive or never-treated hypertensive subjects, who had plasma PTH and calcium concentrations predominantly within the normal range. Passive head
Search for other papers by Athanasios Zervas in
Google Scholar
PubMed
National and Kapodistrian University of Athens Medical School, ‘Aghia Sophia’ Children’s Hospital, Athens, Greece
Search for other papers by George Chrousos in
Google Scholar
PubMed
Search for other papers by Sarantis Livadas in
Google Scholar
PubMed
fact that the majority of them were overweight or obese would rule out insufficient nutrient intake ( 18 ). Iatrogenic causes could, of course, also be ruled out as well as constitutional delay of growth and puberty granted that children with the latter
Search for other papers by Xingrong Tan in
Google Scholar
PubMed
Search for other papers by Wenjing Hu in
Google Scholar
PubMed
Search for other papers by Shan Yang in
Google Scholar
PubMed
Search for other papers by Han Dai in
Google Scholar
PubMed
Search for other papers by Shangcheng Xu in
Google Scholar
PubMed
Search for other papers by Gangyi Yang in
Google Scholar
PubMed
Search for other papers by Ling Li in
Google Scholar
PubMed
Search for other papers by Shiguo Tang in
Google Scholar
PubMed
Search for other papers by Yi Wang in
Google Scholar
PubMed
was approved by the Human Ethics Committee of Chongqing Medical University. According to Chinese Diabetes Society criteria (CDS guideline 2017), MetS components were (1) central obesity (waist circumference; WC ≥85 cm); (2) triglyceride (TG) ≥1.7 mmol
Department of Endocrinology and Diabetology, The Children’s Memorial Health Institute, Warsaw, Poland
Search for other papers by Agnieszka Bogusz in
Google Scholar
PubMed
Search for other papers by Svenja Boekhoff in
Google Scholar
PubMed
Search for other papers by Monika Warmuth-Metz in
Google Scholar
PubMed
Search for other papers by Gabriele Calaminus in
Google Scholar
PubMed
Search for other papers by Maria Eveslage in
Google Scholar
PubMed
Search for other papers by Hermann L Müller in
Google Scholar
PubMed
= 0.002; at last visit: +2.87 SD, range: −0.81 to 11.11 SD, P = 0.001). The development of severe obesity in patients with a + p HL was due to significant weight increase during the first year after diagnosis ( P < 0.001). Further significant
Guangdong Provincial Key Laboratory of Diabetology, Guangzhou, China
Department of Ultrasound, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China
Search for other papers by Riying Liang in
Google Scholar
PubMed
Guangdong Provincial Key Laboratory of Diabetology, Guangzhou, China
Search for other papers by Meijun Wang in
Google Scholar
PubMed
Guangdong Provincial Key Laboratory of Diabetology, Guangzhou, China
Search for other papers by Chang Fu in
Google Scholar
PubMed
Guangdong Provincial Key Laboratory of Diabetology, Guangzhou, China
Search for other papers by Hua Liang in
Google Scholar
PubMed
Guangdong Provincial Key Laboratory of Diabetology, Guangzhou, China
Search for other papers by Hongrong Deng in
Google Scholar
PubMed
Guangdong Provincial Key Laboratory of Diabetology, Guangzhou, China
Search for other papers by Ying Tan in
Google Scholar
PubMed
Guangdong Provincial Key Laboratory of Diabetology, Guangzhou, China
Search for other papers by Fen Xu in
Google Scholar
PubMed
Guangdong Provincial Key Laboratory of Diabetology, Guangzhou, China
Search for other papers by Mengyin Cai in
Google Scholar
PubMed
Introduction Chronic kidney disease (CKD) is increasing worldwide, and obesity is a major risk factor for the development of CKD ( 1 , 2 ) that could be independent of hypertension, diabetes, and dyslipidemia ( 3 ). The pathological features
Search for other papers by Ahmet Uçar in
Google Scholar
PubMed
Search for other papers by Nurçin Saka in
Google Scholar
PubMed
Search for other papers by Firdevs Baş in
Google Scholar
PubMed
Search for other papers by Nihal Hatipoğlu in
Google Scholar
PubMed
Search for other papers by Rüveyde Bundak in
Google Scholar
PubMed
Search for other papers by Feyza Darendeliler in
Google Scholar
PubMed
distribution in non-obese girls with and without precocious pubarche: central adiposity related to insulinaemia and androgenemia from prepuberty to postmenarche . Clinical Endocrinology 2003 58 372 – 379 . ( doi:10.1046/j.1365-2265.2003.01728.x
Search for other papers by Chan Sub Park in
Google Scholar
PubMed
Search for other papers by Jihye Choi in
Google Scholar
PubMed
Search for other papers by Min-Ki Seong in
Google Scholar
PubMed
Search for other papers by Sung-Eun Hong in
Google Scholar
PubMed
Search for other papers by Jae-Sung Kim in
Google Scholar
PubMed
Search for other papers by In-Chul Park in
Google Scholar
PubMed
Search for other papers by Hyesil Seol in
Google Scholar
PubMed
Search for other papers by Woo Chul Noh in
Google Scholar
PubMed
Search for other papers by Hyun-Ah Kim in
Google Scholar
PubMed
-010-0990-0 ) 8 Harvie M Hooper L Howell AH . Central obesity and breast cancer risk: a systematic review . Obesity Reviews 2003 4 . ( https://doi.org/10.1046/j.1467-789X.2003.00108.x ) 9 van der Hage JA van den Broek LJ Legrand C Clahsen PC
epiWELL, LLC, Ithaca, New York, USA
Search for other papers by Magnolia Ariza-Nieto in
Google Scholar
PubMed
Search for other papers by Joshua B Alley in
Google Scholar
PubMed
Search for other papers by Sanjay Samy in
Google Scholar
PubMed
Search for other papers by Laura Fitzgerald in
Google Scholar
PubMed
Search for other papers by Francoise Vermeylen in
Google Scholar
PubMed
Search for other papers by Michael L Shuler in
Google Scholar
PubMed
Search for other papers by José O Alemán in
Google Scholar
PubMed
key regulator of normal liver function ( 9 ). The liver’s sensitivity to environmental factors ( 10 ), including physical activity and central metabolic functions ( 11 ) make it an important mediator of whole body homeostasis. Beyond the genome
Search for other papers by Metin Guclu in
Google Scholar
PubMed
Search for other papers by Sinem Kiyici in
Google Scholar
PubMed
Search for other papers by Zulfiye Gul in
Google Scholar
PubMed
Search for other papers by Sinan Cavun in
Google Scholar
PubMed
liraglutide 3 mg/day has also been recently approved for the treatment of obesity. GLP-1 agonists are potential regulators of feeding behavior through their ability to inhibit gastric emptying, reduce food intake and induce satiety ( 4 , 5 ), but the exact
Search for other papers by Emanuela Zaharieva in
Google Scholar
PubMed
Search for other papers by Zdravko Kamenov in
Google Scholar
PubMed
Search for other papers by Tsvetelina Velikova in
Google Scholar
PubMed
Search for other papers by Adelina Tsakova in
Google Scholar
PubMed
Search for other papers by Yosif El-Darawish in
Google Scholar
PubMed
Search for other papers by Haruki Okamura in
Google Scholar
PubMed
helper immune response ( 3 , 4 ). Apart from its place in immune defense against infective pathogens, IL-18 participates in the pathogenesis of atopic, autoimmune and chronic inflammatory diseases ( 3 , 4 ). Obesity and type 2 diabetes (T2D) have been